These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10477047)

  • 41. Anti-obesity effect of two different levels of dehydroepiandrosterone in lean and obese middle-aged female Zucker rats.
    Cleary MP; Zisk JF
    Int J Obes; 1986; 10(3):193-204. PubMed ID: 2944850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of Diet and Dehydroepiandrosterone on Hypothalamic Monoamine Neurotransmitters in Zucker Rats.
    Svec F; Porter J
    Nutr Neurosci; 1999; 2(5):337-45. PubMed ID: 27415806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LY226936 administered orally and centrally to obese Zucker rats suppresses food intake and body weight gain.
    Shaw WN; Clemens JA; Panetta JA
    Obes Res; 1994 Sep; 2(5):458-68. PubMed ID: 16353597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions.
    Choi S; Jonak EM; Simpson L; Patil V; Fernstrom JD
    Brain Res; 2002 Feb; 928(1-2):30-9. PubMed ID: 11844469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice.
    Abdallah AH
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):395-402. PubMed ID: 5715411
    [No Abstract]   [Full Text] [Related]  

  • 47. Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?
    Roth JD; Rowland NE
    Eur J Pharmacol; 1999 Jun; 373(2-3):127-34. PubMed ID: 10414430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala.
    Javed A; Kamradt MC; Van de Kar LD; Gray TS
    Neuroscience; 1999 Mar; 90(3):851-8. PubMed ID: 10218785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of DHEA on macronutrient selection by Zucker rats.
    Svec F; Porter J
    Physiol Behav; 1996; 59(4-5):721-7. PubMed ID: 8778858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic anorexic and behavioural effects of the fenfluramine metabolite, norfenfluramine: an evaluation of its role in the actions of fenfluramine.
    Goudie AJ; Taylor M; Wheeler TJ
    Psychopharmacologia; 1974; 38(1):67-74. PubMed ID: 4851021
    [No Abstract]   [Full Text] [Related]  

  • 51. Activation of central melanocortin pathways by fenfluramine.
    Heisler LK; Cowley MA; Tecott LH; Fan W; Low MJ; Smart JL; Rubinstein M; Tatro JB; Marcus JN; Holstege H; Lee CE; Cone RD; Elmquist JK
    Science; 2002 Jul; 297(5581):609-11. PubMed ID: 12142539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y.
    Rouru J; Pesonen U; Koulu M; Huupponen R; Santti E; Virtanen K; Rouvari T; Jhanwar-Uniyal M
    Eur J Pharmacol; 1995 Jan; 273(1-2):99-106. PubMed ID: 7737322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.
    Cooper SJ; Dourish CT; Barber DJ
    Br J Pharmacol; 1990 Jan; 99(1):65-70. PubMed ID: 2331576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
    Lew R; Weisenberg B; Vosmer G; Seiden LS
    Synapse; 1997 May; 26(1):36-45. PubMed ID: 9097403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary influences on the acute effects of anorectic drugs.
    Kanarek RB; Glick AL; Marks-Kaufman R
    Physiol Behav; 1991 Jan; 49(1):149-52. PubMed ID: 2017468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.
    Goodall EM; Cowen PJ; Franklin M; Silverstone T
    Psychopharmacology (Berl); 1993; 112(4):461-6. PubMed ID: 7871058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of three anorectic drugs on brain GABA levels and synthesis in the Zucker rat.
    Orosco M; Bremond J; Jacquot C; Cohen Y
    Gen Pharmacol; 1983; 14(3):333-6. PubMed ID: 6873623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of dehydroepiandrosterone and clofibric acid treatments in obese Zucker rats.
    Mohan PF; Cleary MP
    J Nutr; 1989 Mar; 119(3):496-501. PubMed ID: 2564047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.
    Kimura M; Tanaka S; Yamada Y; Kiuchi Y; Yamakawa T; Sekihara H
    Endocrinology; 1998 Jul; 139(7):3249-53. PubMed ID: 9645700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exposure to sweetened solutions enhances the anorectic effect of naloxone but not d-fenfluramine.
    Yeomans MR; Clifton PG
    Physiol Behav; 1997 Aug; 62(2):255-62. PubMed ID: 9251966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.